December 17, 2021
Yet another year is coming to a close, marking another groundbreaking year in medicine. 2021 continued to test the healthcare system and its dedicated professionals with COVID-19 surges and viral variants, rising cases of chronic disease, and nationwide health crises demanding immediate attention.
In line with the A4M mission to disseminate the latest knowledge in modern medicine, we strive to keep clinicians up to date and well-equipped to tackle any clinical challenge with our weekly blog articles. From the role of hormonal health in immunocompetence to the latest successes in Alzheimer’s disease therapeutics, topics featured on the A4M blog highlight essential developments in the industry. To wrap up the year, we compiled a list of our readers’ favorite blogs from 2021.
April 22, 2021
Currently, the growing aging population is leading to an unprecedented rise in older Americans. The number of Americans aged 65 years and older is projected to double by 2060, contributing to an increase in the prevalence of age-related diseases, including Alzheimer’s disease (AD) and related dementias (ADRD). Today, an estimated 5.8 million Americans are living with AD. By 2050, that number is projected to surge to 14 million.
April 2, 2021
Accounting for up to 80% of all dementia cases, Alzheimer’s disease (AD) currently affects over 50 million people across the globe. With 10 million new cases of dementia diagnosed each year, this number is expected to increase with a steadily rising aging population leading experts to forecast there will be nearly 152 million dementia patients by the year 2050. The significant caregiving and economic burden of this condition necessitate innovations in therapeutics that will enable clinicians to implement effective prevention and treatment methods. Today, the socio-economical cost of dementia is estimated at $1 trillion – and this is expected to double by the end of the decade if rates do not slow down.